UNRELATED DONOR REDUCED INTENSITY ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR RELAPSED AND REFRACTORY HODGKIN LYMPHOMA

Myeloablative allogeneic hematopoietic cell transplantation (HCT) may cure patients with relapsed or refractory Hodgkin Lymphoma (HL), but is associated with a high treatment-related mortality (TRM). Reduced intensity and nonmyeloablative (RIC/NST) conditioning regimens aim to lower TRM. We analyzed...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Devetten, Marcel P., Hari, Parameswaran N., Carreras, Jeanette, Logan, Brent R., van Besien, Koen, Bredeson, Christopher N., Freytes, César O., Peter Gale, Robert, Gibson, John, Giralt, Sergio A., Goldstein, Steven C., Gupta, Vikas, Marks, David I., Maziarz, Richard T., Vose, Julie M., Lazarus, Hillard M., Anderlini, Paolo
Format: Artigo
Idioma:Inglês
Publicat: 2009
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2929570/
https://ncbi.nlm.nih.gov/pubmed/19135949
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2008.11.011
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars